Literature DB >> 21326723

Emerging local ablation techniques.

Michael J Stone1, Bradford J Wood.   

Abstract

Local ablation technologies for hepatic malignancy have developed rapidly in the past decade, with advances in several percutaneous or externally delivered treatment methods including radiofrequency ablation, microwave ablation, laser ablation, and high-intensity focused ultrasound. Research has focused on increasing the size of the ablation zone and minimizing heat-sink effects. More recent developments include improvements in treatment planning and navigation with integration of several imaging modalities, as well as automated delivery of the ablation through robotics. These improvements will allow increased consistency in treatment delivery and will facilitate translation to the community setting. Combination therapies with multimodality guidance are on the cutting edge of image-guided, minimally invasive cancer therapies. Local ablation is being combined with regional therapies, such as arterial chemoembolization and local activation of systemically administered drugs, with promising results. Potential combinations with local ablation also include external radiation therapy and antitumor immune modulation. Image-guided oncology is emerging as an important part of the interventional radiology practice, thanks in part to the innovation and imaging background that lies at the roots of our discipline.

Entities:  

Keywords:  Local ablation; high-intensity focused ultrasound; laser; microwave; treatment planning

Year:  2006        PMID: 21326723      PMCID: PMC3036306          DOI: 10.1055/s-2006-939844

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  42 in total

1.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

Authors:  David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

2.  Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation.

Authors:  John R Leyendecker; Gerald D Dodd; Glenn A Halff; Victor A McCoy; Dacia H Napier; Linda G Hubbard; Kedar N Chintapalli; Shailendra Chopra; W Kenneth Washburn; Robert M Esterl; Francisco G Cigarroa; Ruth E Kohlmeier; Francis E Sharkey
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

3.  Use of overpressure to assess the role of bubbles in focused ultrasound lesion shape in vitro.

Authors:  M R Bailey; L N Couret; O A Sapozhnikov; V A Khokhlova; G ter Haar; S Vaezy; X Shi; R Martin; L A Crum
Journal:  Ultrasound Med Biol       Date:  2001-05       Impact factor: 2.998

4.  Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience.

Authors:  Kristin M Dittmar; Jianwu Xie; Finie Hunter; Cameron Trimble; Monica Bur; Victor Frenkel; King C P Li
Journal:  Radiology       Date:  2005-03-29       Impact factor: 11.105

Review 5.  Multiple applicator approaches for radiofrequency and microwave ablation.

Authors:  D Haemmerich; F T Lee
Journal:  Int J Hyperthermia       Date:  2005-03       Impact factor: 3.914

6.  Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue.

Authors:  Yukio Kaneko; Toshiyuki Maruyama; Kenji Takegami; Toshiaki Watanabe; Hiroshi Mitsui; Kazuyuki Hanajiri; Hirokazu Nagawa; Yoichiro Matsumoto
Journal:  Eur Radiol       Date:  2005-03-01       Impact factor: 5.315

7.  Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy.

Authors:  Toshiya Shibata; Yuji Iimuro; Yuzo Yamamoto; Yoji Maetani; Fumie Ametani; Kyo Itoh; Junji Konishi
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

8.  Focused microwave phased array thermotherapy for ablation of early-stage breast cancer: results of thermal dose escalation.

Authors:  Hernan I Vargas; William C Dooley; Robert A Gardner; Katherine D Gonzalez; Rose Venegas; Sylvia H Heywang-Kobrunner; Alan J Fenn
Journal:  Ann Surg Oncol       Date:  2004-02       Impact factor: 5.344

9.  Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.

Authors:  Feng Wu; Zhi-Biao Wang; Cheng-Bing Jin; Jun-Ping Zhang; Wen-Zhi Chen; Jin Bai; Jian-Zhong Zou; Hui Zhu
Journal:  Ultrasound Med Biol       Date:  2004-04       Impact factor: 2.998

10.  Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.

Authors:  H-X Xu; X-Y Xie; M-D Lu; J-W Chen; X-Y Yin; Z-F Xu; G-J Liu
Journal:  Clin Radiol       Date:  2004-01       Impact factor: 2.350

View more
  4 in total

1.  Major trends in the imaging sciences: 2007 Eugene P. Pendergrass New Horizons Lecture.

Authors:  Elias A Zerhouni
Journal:  Radiology       Date:  2008-11       Impact factor: 11.105

2.  Evaluation of the Heat Sink Effect After Transarterial Embolization When Performed in Combination with Thermal Ablation of the Liver in a Rabbit Model.

Authors:  Charles J Puza; Qi Wang; Charles Y Kim
Journal:  Cardiovasc Intervent Radiol       Date:  2018-07-23       Impact factor: 2.740

3.  Active contour configuration model for estimating the posterior ablative margin in image fusion of real-time ultrasound and 3D ultrasound or magnetic resonance images for radiofrequency ablation: an experimental study.

Authors:  Junkyo Lee; Min Woo Lee; Dongil Choi; Dong Ik Cha; Sunyoung Lee; Tae Wook Kang; Jehoon Yang; Jaemoon Jo; Won-Chul Bang; Jongsik Kim; Dongkuk Shin
Journal:  Ultrasonography       Date:  2017-12-21

4.  Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma.

Authors:  Yao Jun Zhang; Min Shan Chen; Yong Chen; Wan Yee Lau; Zhenwei Peng
Journal:  JAMA Netw Open       Date:  2021-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.